- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01876277
Body Image Issues in Boys Being Treated at the Royal Marsden
What Are the Psychosocial Implications of Body Image Issues in Adolescent Males With Cancer?
In adolescence, the effects of cancer and its treatment can lead to bodily changes such as hair loss, weight loss or gain, amputations, scars and developmental delay. As treatments for childhood cancers improve and life expectancy increases, more adolescents have to deal with the effects of cancer and the treatment on their bodies throughout their lives.
Body image can be defined as "The mental image we hold of our bodies". There are two aspects to this, how we "see" our size/shape/weight etc, and then how we feel about this. Often the actual change in body does not always predict how people cope with it, or how they feel about it.
Prior research suggests, and clinical experiences suggests that body image issues arise for at least some adolescents with cancer, however it is unknown whether a disturbance in body image is seen as distressing for the adolescent, or how this affects them psychologically.
Body image problems were always seen as a typically female problem, and therefore researchers have often neglected to look at the issues for men. There is currently no research specifically addressing the impact of body image in adolescent boys with cancer.
This research will involve interviewing adolescent males with cancer with the aims to find out;
- What the body image issues are, if any for this group.
- How any body image issues might affect them, particularly psychologically.
- What helps or hinders this group maintain a positive body image, or stop it having a negative impact on them psychologically.
It is hoped that this will help to inform psychological treatments for body image difficulties in the future.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
London
-
Sutton, London, United Kingdom, SM2 5PT
- Royal Marsden Hopstial
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male- as this research has identified a need for research with this particular group.
- Aged between 13 and 21 (inclusive)as this research is focussing on adolescents and we have defined the age range of adolescence as 13 to 21, in line with other research on adolescence.
- Have a diagnosis of cancer (any type)as this study is not focussing on any particular type of cancer and this will ensure a sufficient pool of participants.
- Have been diagnosed for at least 6 months as issues about adjusting to the diagnosis will be less prevalent at this time and they are likely to have received some treatment for cancer which often produces some of the bodily changes that may affect their body image.
- Have a prognosis of more than 3 months, as it would be unethical to interview people in the final stages of terminal cancer as end of life issues would be more prevalent. Three months was decided upon because often this is the length of time given to patients when it is decided that treatment is no longer indicated and their illness is considered terminal. We would not contact anyone whose cancer was considered terminal.
- Have had treatment within the past 5 years, because beyond this time they are less likely to have body image issues and other issues or than cancer could be more prevalent for them, so they are not suitable participants.
- Able to participate in the interview verbally and in English because the qualitative method requires detailed analysis of the texts and translation may lead to a loss in some of the meaning that is crucial for this research.
Exclusion Criteria:
- Any participant who did not meet all of the inclusion criteria would be excluded.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Adolescent males with cancer
Males aged 13-21 who have been treated at the Royal Marsden Hospital for cancer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Qualitative Interview Schedule
Time Frame: 1 hour
|
Interview schedule developed by researcher to act as topic guide for interview.
|
1 hour
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Annabel Christopher, BSc, University of Surrey
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 890-PSY-13
- CCR3985 (Other Identifier: Royal Marsden NHS Foundation Trust)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States